Halotestin by Dragon Pharma

Fluoxymesterone — Halotestin by Dragon Pharma

Halotestin is Dragon Pharma's formulation of oral Fluoxymesterone at 10mg per tablet — one of the most androgenically potent oral steroids ever developed, with an androgenic ratio of approximately 1,600 versus testosterone's baseline of 100. Unlike most mass-building oral steroids, Halotestin produces minimal weight gain while delivering exceptional strength and aggression enhancement, making it used almost exclusively as a pre-competition or pre-event compound.

Also searched as: Fluoxymesterone 10mg, Halotestin tabs, Halo steroid, Halotestin Dragon Pharma.

What Is Fluoxymesterone (Halotestin)?

Fluoxymesterone is a 17-alpha-methylated synthetic testosterone derivative developed by Upjohn in the 1950s. Originally approved for several medical indications including hypogonadism, delayed puberty and — critically — the treatment of breast cancer in postmenopausal women, reflecting its potent anti-estrogenic environment despite being an androgen. In athletic use, Halotestin's primary value is neurological: it does not build meaningful mass, but produces acute strength and aggression enhancement used in the final days before powerlifting competition or combat sports events.

Why Halotestin Does Not Aromatise — Despite Testosterone-Like Structure

A genuine information gap: Fluoxymesterone is structurally derived from testosterone but does not aromatise — a non-obvious fact given its structural similarity:

• Testosterone aromatises because the aromatase enzyme converts its A-ring structure — specifically, it removes the C-19 methyl group and creates the characteristic aromatic A-ring of estrogen
• Fluoxymesterone has two fluorine substitutions (at C-9 and the 11-beta hydroxyl group) that prevent the aromatase enzyme from processing the A-ring — the fluorine atoms effectively block the enzymatic reaction required for conversion
• This means Fluoxymesterone produces no estrogen conversion, no water retention and no gynecomastia from the compound itself — while still being an extremely potent androgen
• The historical use in breast cancer treatment makes chemical sense: an extremely potent androgen that doesn't convert to estrogen can suppress estrogen-driven cancer cell proliferation in a high-androgen environment without adding estrogenic fuel

The Neurobiological Mechanism Behind Halotestin's Aggression Effect

Halotestin's aggression effect is regularly described as a "side effect" in competitor content — rarely explained mechanistically:

• Fluoxymesterone and its metabolites interact with GABA-A receptors in the central nervous system — the same receptor family targeted by anxiolytics and alcohol
• Specifically, androgenic metabolites of Fluoxymesterone act as neuroactive steroids (neurosteroids) that modulate GABA-A receptor subunit composition and sensitivity in brain regions governing aggression, confidence and competitive drive
• This neurosteroid activity is distinct from the peripheral androgenic effects — it operates at the CNS level, producing the characteristic psychological state of elevated competitive drive, reduced fear response and increased willingness to push through pain that Halotestin users describe
• This is why Halotestin's aggression effect is qualitatively different from simply "elevated androgens" — it is a direct neurological action, not just a peripheral hormonal effect that filters through the CNS

Halotestin vs Other Pre-Event Strength Compounds

Effects and Benefits

• Exceptional acute strength increases — consistently cited as one of the most pronounced strength-to-mass ratio effects of any oral steroid
• Significant aggression and competitive drive enhancement through direct neurosteroid CNS activity
• No aromatisation — no water retention or estrogenic effects
• Dry, hard appearance — minimal weight gain makes it useful in weight-class sports where staying within a weight category is essential
• Increased red blood cell production — documented haematological effect that improves oxygen delivery and training endurance

Dosage and Administration

With an ~9-hour half-life, Halotestin is typically taken once or twice daily. Due to its severe hepatotoxicity — among the highest of any oral steroid — cycle length is strictly limited to 2-4 weeks with liver enzyme monitoring before and after. Most powerlifters and strength athletes restrict use to the final 2-4 weeks of contest preparation or use a single dose on competition day.

Side Effects

• Severe hepatotoxicity — liver enzyme elevation is rapid and significant even at short cycle lengths; monitoring is essential
• Extreme androgenic effects — acne, accelerated hair loss in predisposed individuals, potential voice changes
• Aggression that extends beyond the training/competition window — the neurosteroid CNS effect does not switch off cleanly between sessions
• Suppression of natural testosterone — Post Cycle Therapy is required
• Significant negative impact on cholesterol (HDL/LDL ratio) — considered more pronounced than most other oral steroids

Building a Protocol Around Halotestin

• Enantat 250 or Cypionat 250 as the testosterone base of the full cycle — Halotestin is added for the final 2-4 weeks only
• Never combine with other hepatotoxic orals — Dianabol, Superdrol, Oral Tren — one oral at a time
• Nolvadex or Clomid for Post Cycle Therapy after the full cycle

Storage and Handling

Store Halotestin at room temperature, away from direct sunlight and moisture. Keep the original packaging sealed until use to maintain tablet potency over the product's shelf life.